Progressing Drug Therapies to Market: The Criticality of Analytical Testing Robustness
November 30th 10am ET | 3pm GMT | 7am PTRegister now →
Ensure a smooth development progression with the right analytical testing support.
Rigorous, effective analytical testing is key in the drug development lifecycle. Because this testing is used to verify control of drug chemistry, it can help identify barriers that prevent movement to the next phase in the development process. That’s why it’s critical to have efficient, accurate and high-quality analytical support for your testing requirements.
Partnering with the right CDMO can mean the difference between quality results and potential setbacks for your program. Join this webinar to hear Cambrex experts discuss:
- Early-phase analytical support for IND submission.
- Transitioning methods from early-phase to late-phase.
- Case studies highlighting how Cambrex applies analytical testing expertise to help progress clients’ drug therapies.
Complete the form to registerRegister now →
Meet the Speakers
Director, Analytical Services at Cambrex
Executive Director, Analytical and Biopharmaceutical Services at Cambrex